0001209191-19-029721.txt : 20190514
0001209191-19-029721.hdr.sgml : 20190514
20190514172811
ACCESSION NUMBER: 0001209191-19-029721
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190512
FILED AS OF DATE: 20190514
DATE AS OF CHANGE: 20190514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tucker Sean
CENTRAL INDEX KEY: 0001652204
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35285
FILM NUMBER: 19824032
MAIL ADDRESS:
STREET 1: 385 OYSTER POINT BLVD., SUITE 9A
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxart, Inc.
CENTRAL INDEX KEY: 0000072444
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 591212264
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 290 UTAH AVE., SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 550-3500
MAIL ADDRESS:
STREET 1: 290 UTAH AVE., SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Aviragen Therapeutics, Inc.
DATE OF NAME CHANGE: 20160413
FORMER COMPANY:
FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20121113
FORMER COMPANY:
FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS
DATE OF NAME CHANGE: 20100719
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-12
0
0000072444
Vaxart, Inc.
VXRT
0001652204
Tucker Sean
290 UTAH AVE., SUITE 200
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Scientific Officer
Stock Option (right to buy)
0.77
2019-05-12
4
A
0
124061
0.00
A
2029-05-11
Common Stock
124061
124061
D
The option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares subject to the option vesting in equal monthly installments over the next 36 months.
/s/ Wouter W. Latour, Attorney-in-Fact for Sean Tucker
2019-05-14